Law Firm Probes Option Care Health Amid Shareholder Concerns
Monteverde & Associates PC has opened an investigation into Option Care Health, a NASDAQ-listed infusion therapy company, on behalf of shareholders.
A New York-based securities law firm has launched an investigation into Option Care Health, Inc. (NASDAQ: OPCH), according to an announcement released October 11, 2026. Monteverde & Associates PC, led by class action attorney Juan Monteverde, is examining potential claims on behalf of the company's shareholders.
The firm, which describes itself as a mergers-and-acquisitions-focused class action practice, was recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. Monteverde & Associates states it has previously recovered millions of dollars for shareholders in similar matters.
Read more Retail Investing Platforms Hit 41M Accounts in Record Quarter →
Details of the specific allegations or legal theories underpinning the Option Care Health probe were not disclosed in the initial announcement. Investigations of this type typically precede formal litigation and are designed to determine whether corporate officers or directors may have breached fiduciary duties owed to investors, often in connection with a merger, acquisition, or other significant corporate transaction.
Option Care Health is one of the largest providers of home and alternate-site infusion services in the United States, making any legal scrutiny of its corporate governance or deal activity of potential interest to retail and institutional investors alike. Shareholders who hold OPCH stock and wish to learn more about their legal rights are generally encouraged to contact the investigating firm directly.
Continue reading at All Financial Services & Investing.
